Lew, M. F., Slevin, J. T., Krüger, R., Martínez Castrillo, J. C., Chatamra, K., Dubow, J. S., . . . Fung, V. S. (2015). Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials. Parkinsonism & related disorders, 21(7), 742-748. https://doi.org/10.1016/j.parkreldis.2015.04.022
Citace podle Chicago (17th ed.)Lew, Mark F., John T. Slevin, Rejko Krüger, Juan Carlos Martínez Castrillo, Krai Chatamra, Jordan S. Dubow, Weining Z. Robieson, Janet A. Benesh, a Victor S.C Fung. "Initiation and Dose Optimization for Levodopa-carbidopa Intestinal Gel: Insights from Phase 3 Clinical Trials." Parkinsonism & Related Disorders 21, no. 7 (2015): 742-748. https://doi.org/10.1016/j.parkreldis.2015.04.022.
Citace podle MLA (9th ed.)Lew, Mark F., et al. "Initiation and Dose Optimization for Levodopa-carbidopa Intestinal Gel: Insights from Phase 3 Clinical Trials." Parkinsonism & Related Disorders, vol. 21, no. 7, 2015, pp. 742-748, https://doi.org/10.1016/j.parkreldis.2015.04.022.